Design and Synthesis of Novel Quinone Inhibitors Targeted to the Redox Function of Apurinic/apyrimidinic Endonuclease 1/redox Enhancing Factor-1 (Ape1/ref-1)

Overview

Journal J Med Chem

Publisher American Chemical Society

Specialty Chemistry

Date 2010 Jan 14

PMID 20067291

Citations 39

Authors

Rodney L Nyland

Meihua Luo

Mark R Kelley

Richard F Borch

Affiliations

Soon will be listed here.

Abstract

The multifunctional enzyme apurinic endonuclease 1/redox enhancing factor 1 (Ape1/ref-1) maintains genetic fidelity through the repair of apurinic sites and regulates transcription through redox-dependent activation of transcription factors. Ape1 can therefore serve as a therapeutic target in either a DNA repair or transcriptional context. Inhibitors of the redox function can be used as either therapeutics or novel tools for separating the two functions for in vitro study. Presently there exist only a few compounds that have been reported to inhibit Ape1 redox activity; here we describe a series of quinones that exhibit micromolar inhibition of the redox function of Ape1. Benzoquinone and naphthoquinone analogues of the Ape1-inhibitor E3330 were designed and synthesized to explore structural effects on redox function and inhibition of cell growth. Most of the naphthoquinones were low micromolar inhibitors of Ape1 redox activity, and the most potent analogues inhibited tumor cell growth with IC(50) values in the 10-20 microM range.

Citing Articles

Investigation of photophysical properties and potential biological applications of substituted tris(polypyridyl)ruthenium(II) complexes.

Sumitha Celin T, Allen Gnana Raj G, Prathima T, Balamurali M Front Chem. 2025; 13:1491598.

PMID: 39963354 PMC: 11830695. DOI: 10.3389/fchem.2025.1491598.

A Potent PDK4 Inhibitor for Treatment of Heart Failure with Reduced Ejection Fraction.

Aizawa K, Ikeda A, Tomida S, Hino K, Sugita Y, Hirose T Cells. 2024; 13(1).

PMID: 38201291 PMC: 10777911. DOI: 10.3390/cells13010087.

APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.

Sahakian L, Robinson A, Sahakian L, Stavely R, Kelley M, Nurgali K Biomolecules. 2023; 13(11).

PMID: 38002251 PMC: 10669584. DOI: 10.3390/biom13111569.

Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330.

Silva L, Stratford R, Messmann R, Kelley M, Quinney S CPT Pharmacometrics Syst Pharmacol. 2023; 13(1):106-117.

PMID: 37884051 PMC: 10787204. DOI: 10.1002/psp4.13061.

Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons.

Malfatti M, Bellina A, Antoniali G, Tell G Cells. 2023; 12(14).

PMID: 37508559 PMC: 10378182. DOI: 10.3390/cells12141895.

References

Xanthoudakis S, Miao G, Curran T . The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc Natl Acad Sci U S A. 1994; 91(1):23-7. PMC: 42878. DOI: 10.1073/pnas.91.1.23. View

Zou G, Karikari C, Kabe Y, Handa H, Anders R, Maitra A . The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol. 2008; 219(1):209-18. DOI: 10.1002/jcp.21666. View

Zou G, Maitra A . Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Mol Cancer Ther. 2008; 7(7):2012-21. PMC: 3569736. DOI: 10.1158/1535-7163.MCT-08-0113. View

Fishel M, He Y, Smith M, Kelley M . Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. Clin Cancer Res. 2007; 13(1):260-7. DOI: 10.1158/1078-0432.CCR-06-1920. View

Georgiadis M, Luo M, Gaur R, Delaplane S, Li X, Kelley M . Evolution of the redox function in mammalian apurinic/apyrimidinic endonuclease. Mutat Res. 2008; 643(1-2):54-63. PMC: 2637456. DOI: 10.1016/j.mrfmmm.2008.04.008. View

Jiang Y, Guo C, Fishel M, Wang Z, Vasko M, Kelley M . Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: use of APE1 small molecule inhibitors to delineate APE1 functions. DNA Repair (Amst). 2009; 8(11):1273-82. PMC: 2765866. DOI: 10.1016/j.dnarep.2009.08.003. View

Luo M, Delaplane S, Jiang A, Reed A, He Y, Fishel M . Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal. 2008; 10(11):1853-67. PMC: 2587278. DOI: 10.1089/ars.2008.2120. View

Gius D, Cao X, Rauscher 3rd F, Cohen D, Curran T, Sukhatme V . Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements. Mol Cell Biol. 1990; 10(8):4243-55. PMC: 360963. DOI: 10.1128/mcb.10.8.4243-4255.1990. View

Evans A, Kelley M . Going APE over ref-1. Mutat Res. 2000; 461(2):83-108. DOI: 10.1016/s0921-8777(00)00046-x. View

10.

Izumi T, Brown D, Naidu C, Bhakat K, Macinnes M, Saito H . Two essential but distinct functions of the mammalian abasic endonuclease. Proc Natl Acad Sci U S A. 2005; 102(16):5739-43. PMC: 556297. DOI: 10.1073/pnas.0500986102. View

11.

Tell G, Quadrifoglio F, Tiribelli C, Kelley M . The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal. 2008; 11(3):601-20. PMC: 2811080. DOI: 10.1089/ars.2008.2194. View

12.

Tremblay M, Sames D . A new fluorogenic transformation: development of an optical probe for coenzyme Q. Org Lett. 2005; 7(12):2417-20. DOI: 10.1021/ol0507569. View

13.

Tell G, Damante G, Caldwell D, Kelley M . The intracellular localization of APE1/Ref-1: more than a passive phenomenon?. Antioxid Redox Signal. 2005; 7(3-4):367-84. DOI: 10.1089/ars.2005.7.367. View

14.

Flader C, Liu J, Borch R . Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase. J Med Chem. 2000; 43(16):3157-67. DOI: 10.1021/jm000179o. View

15.

Clegg N, Paruthiyil S, Leitman D, Scanlan T . Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands. J Med Chem. 2005; 48(19):5989-6003. DOI: 10.1021/jm050226i. View

16.

Ohkawa S, Terao S, Terashita Z, Shibouta Y, Nishikawa K . Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives. J Med Chem. 1991; 34(1):267-76. DOI: 10.1021/jm00105a042. View